Uniplan Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-44,453
Closed -$3.41M 137
2021
Q4
$3.41M Buy
+44,453
New +$3.54M 0.19% 91
2018
Q1
Sell
-218,943
Closed -$11.8M 123
2017
Q4
$11.8M Sell
218,943
-17,299
-7% -$959K 0.48% 63
2017
Q3
$14.4M Buy
236,242
+3,097
+1% +$188K 0.61% 51
2017
Q2
$14.3M Buy
233,145
+7,646
+3% +$465K 0.63% 48
2017
Q1
$13.7M Sell
225,499
-154,886
-41% -$9.4M 0.62% 46
2016
Q4
$12.6M Buy
380,385
+132,186
+53% +$7.74M 0.57% 51
2016
Q3
$14.8M Buy
248,199
+13,437
+6% +$786K 0.67% 46
2016
Q2
$12.9M Sell
234,762
-31,781
-12% -$1.69M 0.58% 49
2016
Q1
$13.5M Sell
266,543
-779
-0.3% -$38.2K 0.66% 49
2015
Q4
$13.5M Sell
267,322
-67,791
-20% -$3.42M 0.65% 52
2015
Q3
$15.8M Sell
335,113
-41,888
-11% -$2.23M 0.76% 48
2015
Q2
$20.5M Buy
+377,001
New +$21.1M 0.93% 43

Other funds holding MRK

Uniplan Investment Counsel's MRK Position: Q1 2022 in Review

Uniplan Investment Counsel sold out of Merck (MRK) in Q1 2022, closing a stake of 44,453 shares — an estimated $3.41M sold.

Uniplan Investment Counsel first reported a position in MRK in Q2 2015 and held it in 12 quarters. The position peaked at $20.5M in Q2 2015. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Uniplan Investment Counsel reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Uniplan Investment Counsel sold 44,453 Merck shares in Q1 2022, an estimated $3.41M.
  • Uniplan Investment Counsel first reported a position in Merck in Q2 2015 and held it in 12 quarters.
  • Uniplan Investment Counsel's Merck position peaked at $20.5M in Q2 2015.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Uniplan Investment Counsel's 13F filing for Q1 2022, filed 16 May 2022.